www.trustedrxapproved.net

Your reliable supplier of generic medications.

Check yourbonu$
Site search:
Obvious advantage Tell a friend and get discount! Want to give it a try?
Categories list

Generic Fenofibrate - Tricor

Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Tricor

Generic Tricor

Fenofibrate 160/200mg

Generic Tricor is used for controlling high cholesterol and triglyceride levels in the blood. It is used in combination with a diet low in cholesterol and saturated fat. Generic Tricor is a lipid-lowering agent. It lowers elevated blood triglyceride levels by making the liver produce fewer triglycerides and increasing the elimination of triglycerides from the blood stream.
More info »

$1.50 Buy now!
Language/Idioma/Sprache:
Social bookmarks:
Testimonials

We have received both parts of the shipment, and my husband and I are very satisfied with the product.

Our billing is certified by:

Secure shopping certificates


Special Offer!

News

  • Impax cited by FDA in manufacturing inspection - FierceDrugDelivery

    Impax cited by FDA in manufacturing inspectionFierceDrugDeliveryThe company was cited last year for issues related to the production of fenofibrate, a high cholesterol treatment, resulting in a recall of 5 lots of the drug, FiercePharmaManufacturing reported.

  • Treatment of chronic hemodialysis patients with low-dose fenofibrate ... - 7thSpace Interactive (press release)

    Treatment of chronic hemodialysis patients with low-dose fenofibrate .

  • Expect strong growth from US in FY13-14 - Moneycontrol.com

    Expect strong growth from US in FY13-14Moneycontrol.

  • Santarus' CEO Presents at Bank of America Merrill Lynch 2012 Health Care ... - Seeking Alpha

    Santarus' CEO Presents at Bank of America Merrill Lynch 2012 Health Care .

  • Santarus Reports First Quarter 2012 Financial Results - MarketWatch (press release)

    Santarus Reports First Quarter 2012 Financial ResultsMarketWatch (press release)FENOGLIDE(fenofibrate) tablets new prescriptions grew 17% and total prescriptions increased 11% for the four-week period ending April 20, 2012, compared with the four-week period ending February 3, 2012, which was just prior to Santarus' initiation of .

bookmark Bookmark this site
Subscribe to the News
Trusted. Rx approved.